Purification of CAR+ T Cells Reveals Impact of Untransduced Cells in CAR-T Drug Product […]
Read More… from Immuno-Oncology Summit – 2024 – Poster Presentation P26
Publication Programs: Discovery Platform
ASGCT – 2024 – Poster Presentation 1775
Gene-Edited Hematopoietic Stem Cells to Enable Next-Generation CAR-T Cell Therapy for the Treatment of AML […]
KEYSTONE SYMPOSIA – 2024 – POSTER PRESENTATION 1040
Uncovering Molecular and Functional Dynamics of Human Hematopoietic Stem Cells during In Vitro Culture for Cell Therapy Manufacturing […]
Read More… from KEYSTONE SYMPOSIA – 2024 – POSTER PRESENTATION 1040
Keystone Symposia – 2024 – Poster Presentation 2538
Leveraging CRISPR/Cas9 and HDR to create an engineered CD33 CAR-T to target AML […]
Read More… from Keystone Symposia – 2024 – Poster Presentation 2538
ASH – 2023 – POSTER PRESENTATION 3425
CD33-Deleted Hematopoietic Cells (Trem-Cel) Are Protected from CD33xCD3 Bispecific Antibody Treatment and Produce Significantly Reduced Levels of Inflammatory Cytokines in Preclinical Studies […]
ASH – 2023 – ORAL PRESENTATION 164
Multimodal Atlas of Paired Diagnosis and Relapse AML Samples Enables Novel Therapeutic Targeting of Surface Antigens […]
SITC – 2023 – POSTER PRESENTATION P260
Novel CLL-1-directed CAR-T cells Mediate Potent Antigen-specific Cytolytic Activity in Mouse Models of Acute Myeloid Leukemia […]
ESGCT – 2023 – Poster Presentation P726
GUMM: A Purpose-Built Computational Workflow for Single Cell Genotyping of Gene Editing Experiments […]
Cold Spring Harbor Lab Meeting – 2023 – Poster Presentation P203
A Single Cell DNA Sequencing Resource and Computational Approach to Quantify CRISPR-Cas9 Gene Editing Allelism […]
Read More… from Cold Spring Harbor Lab Meeting – 2023 – Poster Presentation P203